Jason David Allen

Professor Allen originates from the UK where he completed his undergraduate degree in Human Movement Studies. He originally came to the U.S. during college summer vacations to coach soccer (1989-92) and ended up staying. After finishing his Ph.D. at Louisiana State University, he completed 12 years as a faculty member at Duke University Medical Center where he directed a Non-Invasive Vascular Research Laboratory. In the four years immediately prior to joining UVA, Professor Allen was the director of the Clinical Exercise and Rehabilitation and the program leader for Clinical Research for the Institute of Sport, Exercise and Active Living (ISEAL) at Victoria University, in Melbourne, Australia.

Professor Allen directs the exercise physiology graduate program in the Department of Kinesiology and holds a secondary appointment in the Division of Cardiovascular Medicine and the Robert M. Berne Cardiovascular Research Center. He is a co-director of the Exercise Physiology Laboratories (Exercise, Vascular & Biochemistry) in the Department of Kinesiology. He teaches graduate courses in Human Physiology and Human Circulatory Physiology, along with an undergraduate course in Clinical Exercise Physiology. He is a fellow and Registered Clinical Exercise Physiologist (RCEP) by the American College of Sports Medicine, and a Registered Vascular Specialist by Cardiovascular Credentialing International.

He is an active member of the Nitric Oxide Society and the American College of Sports Medicine.

Fellowship, Duke University Medical Center, 2004
Ph.D., Louisiana State University, 2001
M.Ed., Western Carolina University, 1996
B.A. (Hons) Carnegie/Leeds Metropolitan University (England), 1992

Curriculum Vitae

Professor Allen’s research program is dedicated to applying rigorous scientific methods to understanding the roles of exercise and novel medicinal interventions in patients with cardiometabolic diseases across the lifespan. The work combines physiological and biochemical techniques in an attempt to better detect markers of disease and develop innovative treatments in clinical human populations. His major focus is peripheral blood flow, endothelial function and nitric oxide (NO) bioavailability and their contributions to physical function and exercise.  

His group has current funding on several grants from the National Institutes of Health (NIH) and other sources related to heart failure, peripheral arterial disease, aging, and sex differences in exercise responses.